Within our guts is a tiny ecosystem populated by trillions of microorganisms. These germs affect digestion, the immune system, and even brain functioning. Scientists have also started investigating the potential role of gut bacteria in psychiatric and neurological conditions, including neurodegenerative diseases like Alzheimers and Parkinsons. If gut microbes prove influential, this could reveal how these diseases work, leading to earlier detection and new treatment targets.
Neurodegenerative diseases progressively damage and kill nerve cells, causing problems with mental or movement function, and sometimes both. Over the past 30 years, these diseases have grown more common with the worlds increasingly older population, yet there are no cures and few effective treatments. Alzheimers and Parkinsons diseases lead the way, affecting millions of people worldwide.
These diseases arise from combinations of genetic, environmental, age-related, and lifestyle factors, but in most cases, doctors cant pinpoint a cause. Given that the brain connects with the gut, scientists are increasingly looking at the possible role of gut microbes.
Much of this research has focused on Parkinsons, which is associated with gastrointestinal issues. But preliminary connections between the gut microbiome and other neurodegenerative diseases, like Alzheimers and amyotrophic lateral sclerosis (ALS), are also emerging.
Bacteria account for the majority of the microorganisms in our guts, and theyre in direct and indirect communication with the nervous system, which controls mental functions, movement, sensory perception, and automatic processes like breathing.
Through a two-way connection called the gut-brain axis, our microbes could be liaising with the brain via nerves and chemical pathways. For example, gut bacteria can synthesise neurotransmitters, the brains molecular messengers, and other chemicals used in the brain. When absorbed by the gut walls and into the bloodstream, these molecules can travel to the brain. The bacteria also interact with immune cells. This could indirectly affect the brain through immune cell signalling pathways, or, in late neurodegenerative disease stages, directly affect the brain. During the late disease stages, its possible that immune cells infiltrate the brain from the bloodstream, through more porous blood vessels.
The role of gut bacteria in neurodegenerative diseases is still an emerging field of research. Theres some rightful scepticism, said Timothy Sampson, assistant professor of physiology at Emory University.
It is still a relatively young field, so there are a lot of unknowns, said Jan Pieter-Konsman, a neuroimmunologist at the University of Bordeaux. Until recently, studies of the gut microbiome and neurodegenerative diseases were limited to comparing microbial communities in people with and without the diseases. Most studies didnt look deeper at the operations within those ecosystems.
Youve got to break down that community to understand those interactions, said Maureen OMalley, a philosophy of microbiology researcher at the University of Sydney. But in the past five years, groups are increasingly drilling into those interactions, studying which specific microbes and molecules could be involved in disease.
Parkinsons disease, in particular, has captured the attention of researchers interested in the gut-brain axis. Gastrointestinal issues, like constipation, often occur in people years before they develop the movement-related symptoms characteristic of the disease.
One of the cardinal features originally of James Parkinsons diagnosis of the shaking palsy, which has become Parkinsons disease, was this observation of intractable constipation in patients, said Lynne Barker, associate professor of cognitive neuroscience at Sheffield Hallam University. The fact that the gut is involved in Parkinsons hasnt been a secret.
Scientists look at bacterial genes in stool samples to approximate the bacterial composition of the gut. These studies have shown that microbiomes of people with Parkinsons differ from those without Parkinsons. These differences arise independently of other influences over the microbiome, like diet. But that leads to this big chicken-and-the-egg problem, said Sampson. Did the disease cause the microbiome to change, or did the change in the microbiome influence the disease?
In a small, preliminary study, Purna Kashyap, professor of medicine and physiology and co-director of the microbiome program at Mayo Clinic, and his team used mouse models of Parkinsons disease and showed that mice needed gut bacteria to develop movement-related symptoms. In germ-free mice, ones without any detectable bacteria, fungi or viruses in or on their bodies, movement problems never materialised.
Studies in rats and mice have also shown that the gut bacteria Escherichia coli make proteins akin to alpha-synuclein protein clumps that form in the brain in Parkinsons disease. In mice engineered to overexpress alpha-synuclein, Sampson has shown that this bacterial protein in the gut exacerbates both alpha-synuclein aggregation in the brain and movement symptoms.
OMalley cautioned that while these animal experiments go deeper than earlier studies, they should be interpreted with caution, since animal studies often fail to replicate in humans. But, she said, I think you can still get some of the suggestive findings that then allow you to build a better model of whats going on.
More recently, a few research groups have started looking for gut microbiome disturbances in other neurodegenerative diseases, like Alzheimers. Protein clumps called beta-amyloid plaques disrupt brain cell functions in people with Alzheimers. Mouse models of Alzheimers disease also suggest a role for gut microbes.
If you keep those mice germ-free, they dont develop as many amyloid plaques, said Barbara Bendlin, a professor of medicine at the University of Wisconsin, Madison. It does really suggest that in some way theres a link between microbes and the development of Alzheimers disease pathology.
As a starting point in human research, Bendlin and her team have studied gut microbiomes of people with Alzheimers disease by analysing stool samples. In a small study of 25 people with Alzheimers and 25 people without, they found that Alzheimers patients had a less diverse bacterial population and different amounts of certain bacteria. They also analysed the cerebrospinal fluid, which surrounds the brain and spinal cord, of participants to look for relationships between Alzheimers-related biomarkers and the gut microbiome.
We found that there were relationships between the gut microbiome and those cerebrospinal fluid biomarkers, even among individuals who were asymptomatic, said Bendlin. That suggested to us that maybe theres a link between the gut and brain pathology thats present even before people develop dementia.
Scientists have also begun exploring links between gut bacteria and ALS, a disease in which neurons powering the muscles gradually die. In a study of mice with a genetic mutation known to cause ALS in some human cases, Eran Blacher, postdoctoral fellow studying the gut-brain axis at the neurology department of Stanford University School of Medicine, and his team showed that gut microbiome changes preceded ALS symptoms. Blacher said that indicated that such changes might have to do with the disease.
The researchers also found that certain gut bacteria produced molecules that altered the disease in mice. Giving the mice a probiotic supplement with that bacteria boosted levels of the molecule nicotinamide and improved their symptoms. Nicotinamide produces key chemicals for cellular pathways scientists think are involved in ALS. So we can change the disease progression and manifestation by treating the mice with specific bacteria, which was very surprising, said Blacher.
Blachers preliminary findings in a small group of human patients supported those results: People with ALS had lower levels of bacterial genes needed for nicotinamide metabolism in their stool samples compared to people without ALS. They also had lower levels of nicotinamide in their blood and cerebrospinal fluid. We are not saying that we were able to cure ALS, or to change anything in disease progression in humans, said Blacher. Rather, larger follow-up studies could reveal more about mechanisms underlying ALS and reveal potential therapy targets.
But overall, the microbiomes role in neurodegenerative diseases remains mysterious. Barkers group is analysing data from a small feasibility study to see whether administering a common probiotic to people with Parkinsons disease could change their microbiome composition or influence quality of life. Unlike earlier work, Barker said her group is looking beyond big-picture changes in microbial communities to zero in on specific bacterial species.
Still, studies are far from revealing microbiome-based treatments for neurodegenerative diseases. Even if some kind of probiotics or dietary changes were shown to be effective at alleviating some symptoms, it wouldnt be a cure for these complicated diseases. If gut microbes are involved in neurodegeneration, scientists also need to figure out how this fits with other potential disease causes.
We have not learned the mechanisms that link that to the brain, and until we firmly know those, were not going to be able to develop effective treatments, said Bendlin.
@JackieRocheleau.
Read more from the original source:
How the Ecosystems in Our Guts Could Be Linked to Brain Disorders - Gizmodo Australia
- Jake Diekman throws BP session for Rangers | MLB.com - MLB.com - August 6th, 2017 [August 6th, 2017]
- Cerebral palsy: Symptoms, diagnosis, treatment - December 5th, 2017 [December 5th, 2017]
- Hypothalamus - the body's thermostat | ASU - Ask A Biologist - December 6th, 2017 [December 6th, 2017]
- When Stroke Affects the Thalamus - Stroke Connection ... - December 28th, 2017 [December 28th, 2017]
- The Endocrine System: Hypothalamus and Pituitary - December 28th, 2017 [December 28th, 2017]
- Hypothalamus - Anatomy, Blood supply and Function | Kenhub - December 28th, 2017 [December 28th, 2017]
- Ulcerative Colitis - Cedars-Sinai - January 6th, 2018 [January 6th, 2018]
- Ulcerative colitis - Treatment - NHS.UK - January 7th, 2018 [January 7th, 2018]
- Business Directory | Uptown Waterloo Business Improvement Area - January 8th, 2018 [January 8th, 2018]
- Will States Continue To Fund Stem Cell Research? : Shots ... - January 28th, 2018 [January 28th, 2018]
- Spinal Cord Injuries - emedicine.medscape.com - February 15th, 2018 [February 15th, 2018]
- Spinal Cord Injuries - spine.org - February 15th, 2018 [February 15th, 2018]
- Journal of Clinical & Experimental Cardiology - Open Access Journals - April 10th, 2018 [April 10th, 2018]
- Cardiology Treatment - Fortis Healthcare - April 10th, 2018 [April 10th, 2018]
- Biology Junction - April 12th, 2018 [April 12th, 2018]
- Managing Right Ventricular Failure in PAH: An Algorithmic ... - April 14th, 2018 [April 14th, 2018]
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in ... - April 22nd, 2018 [April 22nd, 2018]
- Cardiovascular Pharmacotherapeutics: William H. Frishman ... - May 13th, 2018 [May 13th, 2018]
- 13 Super Foods Good for Eczema - Top Eczema Treatments - May 15th, 2018 [May 15th, 2018]
- Diagnosis & Treatment of Parkinson's - ParkinsonsDisease.net - May 30th, 2018 [May 30th, 2018]
- Arizona Heart Rhythm Center - June 10th, 2018 [June 10th, 2018]
- Ayurvedic Medicines for Ulcerative Colitis | Natural ... - June 21st, 2018 [June 21st, 2018]
- Weinstein Cardiovascular Development and Regeneration Meeting - June 30th, 2018 [June 30th, 2018]
- Ulcerative Colitis Information Centre - July 31st, 2018 [July 31st, 2018]
- Sudden Death in Dogs - Pet Health Network | Pet Health ... - August 7th, 2018 [August 7th, 2018]
- Coronary Heart Disease - Ischaemic heart disease - British ... - August 21st, 2018 [August 21st, 2018]
- Cardiac Rehabilitation: Overview, History and Definition ... - August 25th, 2018 [August 25th, 2018]
- Difference between Cardiac Arrest and Respiratory Arrest ... - August 25th, 2018 [August 25th, 2018]
- ECM for Pericardial Closure - Aziyo - August 25th, 2018 [August 25th, 2018]
- Adult Mental Health | Georgia Department of Behavioral Health ... - September 6th, 2018 [September 6th, 2018]
- Mental Health | ECLKC - September 6th, 2018 [September 6th, 2018]
- Mental Health - The Church of Jesus Christ of Latter-day Saints - September 6th, 2018 [September 6th, 2018]
- Center for Vascular Biology - Home | UConn Health - September 22nd, 2018 [September 22nd, 2018]
- # Diabetes Stem Cell Research Diabetes Care Measures - September 30th, 2018 [September 30th, 2018]
- Cardiac Rhythm Disturbances | The Patient Guide to Heart ... - November 2nd, 2018 [November 2nd, 2018]
- Arrhythmia | Cleveland Clinic - November 2nd, 2018 [November 2nd, 2018]
- Hyperbaric Oxygen Therapy for Wound Healing | Johns ... - November 13th, 2018 [November 13th, 2018]
- NIMH Home - November 24th, 2018 [November 24th, 2018]
- What is an interventional cardiologist? | Heart Surgeries ... - November 26th, 2018 [November 26th, 2018]
- Molecular Cardiology Research Institute Boston | Tufts ... - November 29th, 2018 [November 29th, 2018]
- Lower vascular plant | botany | Britannica.com - December 7th, 2018 [December 7th, 2018]
- Welcome to the ABG Tutorial Welcome to Hansen - December 12th, 2018 [December 12th, 2018]
- Cardiac catheterization - Wikipedia - December 12th, 2018 [December 12th, 2018]
- Stem Cell Research & Therapy | Home page - December 22nd, 2018 [December 22nd, 2018]
- Journal of Stem Cell Research and Therapy- Open Access ... - December 22nd, 2018 [December 22nd, 2018]
- Stem-cell therapy - Wikipedia - December 22nd, 2018 [December 22nd, 2018]
- Cardiology and Interventional Cardiology - December 23rd, 2018 [December 23rd, 2018]
- Rhode Island Interventional Cardiology | Cardiovascular ... - December 23rd, 2018 [December 23rd, 2018]
- Interventional Cardiology Certification Policies | ABIM.org - December 23rd, 2018 [December 23rd, 2018]
- Interventional Cardiology - Boston Scientific - December 23rd, 2018 [December 23rd, 2018]
- 9 Benefits of Human Growth Hormone (Along with Side ... - December 27th, 2018 [December 27th, 2018]
- Growth hormone deficiency - Wikipedia - December 27th, 2018 [December 27th, 2018]
- Dr. Lorrie Kirshenbaum, Cardiac Gene Biology | St ... - January 28th, 2019 [January 28th, 2019]
- Cardiomyopathy - CardioSmart - February 8th, 2019 [February 8th, 2019]
- Centenary Institute | Medical Research, Life Saving Research - February 24th, 2019 [February 24th, 2019]
- Cardiovascular Medicine | Department of Medicine - March 29th, 2019 [March 29th, 2019]
- Rapid Test Market 2019 with Recent Trends, Revenue, Demand and Top Manufactures- Bureau Veritas, SGS SA, Intertek Group plc, Eurofins Scientific -... - October 11th, 2019 [October 11th, 2019]
- Medical Imaging Equipment Market Research Report 2019: Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast To... - October 11th, 2019 [October 11th, 2019]
- Analysis on the Global DNA Read, Write & Edit Market, 2017-2019 and Forecast to 2024 - Yahoo Finance - October 11th, 2019 [October 11th, 2019]
- Cardiac Surgery Instruments Market is Expected to Tread a Steady Growth Trajectory by Clocking a CAGR of 5.9% from 2017 to 2022 - Health News Office - October 24th, 2019 [October 24th, 2019]
- PEDIATRIC MEDICAL DEVICES MARKET IS PROJECTED TO EXPAND AT A CAGR OF 8.0% FROM 2018 TO 2026 - Health News Office - November 1st, 2019 [November 1st, 2019]
- myTAIHEART Test Provides Evidence for Injury from Biopsy of Heart Transplant Recipients Cardiology2.0 - Cardiology2.0 - November 1st, 2019 [November 1st, 2019]
- Mental health and your heart - British Heart Foundation - November 19th, 2019 [November 19th, 2019]
- BUZZ-U.S. STOCKS ON THE MOVE-Cango, Gulfport Energy, Abiomed, Standard Diversified, Wanda Sports, Eidos - Nasdaq - November 19th, 2019 [November 19th, 2019]
- Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT - AJMC.com Managed Markets Network - November 19th, 2019 [November 19th, 2019]
- Hundreds walk to defeat ALS in Ancient City - St. Augustine Record - November 22nd, 2019 [November 22nd, 2019]
- Living with Lung Cancer: The Silver Linings - Curetoday.com - November 22nd, 2019 [November 22nd, 2019]
- Building the human spinal cord atlas - SynBioBeta - November 22nd, 2019 [November 22nd, 2019]
- The Week That Wasn't: Keto and the Flu, Human Cyborg, Duvet Disease - Medscape - November 22nd, 2019 [November 22nd, 2019]
- ALS advance offers hope for those diagnosed with deadly disease - WRAL.com - November 22nd, 2019 [November 22nd, 2019]
- ALS Stem Cell Therapy Developer Seeks Amendment to its AstroRx Trial - ALS News Today - November 22nd, 2019 [November 22nd, 2019]
- Former Boston Globe writer, current NHL executive Snow diagnosed with ALS | College Hockey - USCHO - December 23rd, 2019 [December 23rd, 2019]
- AB Science announces the publication of new results in the peer-reviewed journal Glia that further support masitinib's potential mode of action in ALS... - December 23rd, 2019 [December 23rd, 2019]
- Christmas in the City thrills homeless families, takes on poignancy with founders ALS diagnosis - The Boston Globe - December 23rd, 2019 [December 23rd, 2019]
- Amylyx Pharmaceuticals Announces AMX0035 Demonstrated Statistically Significant Treatment Benefit for People with ALS in the CENTAUR Trial - Business... - December 23rd, 2019 [December 23rd, 2019]
- RADICAVA (edaravone) - December 23rd, 2019 [December 23rd, 2019]
- List of Amyotrophic Lateral Sclerosis Medications (5 Compared ... - December 23rd, 2019 [December 23rd, 2019]
- Neuropore Completes Phase 1 Clinical Trial in Healthy Volunteers with NPT520-34, a Therapeutic Candidate Aimed at Treating Parkinson's Disease and... - January 14th, 2020 [January 14th, 2020]
- Comprehensive Analysis on Prostacyclin Market based on types and application - Technology Magazine - January 18th, 2020 [January 18th, 2020]
- N.J. karate legend who inspired thousands loses battle with ALS - NJ.com - January 18th, 2020 [January 18th, 2020]